Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters
- PMID: 873619
- PMCID: PMC421493
- DOI: 10.1128/iai.16.1.93-98.1977
Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters
Abstract
The distribution of Mycoplasma pneumoniae infection in the respiratory tract and the extent of pulmonary pathology were determined by the site of deposition and the number of organisms administered to hamsters. Infection of the upper and lower areas of the respiratory tract occurred when organisms were introduced into both areas by small-particle aerosol (2.3 micrometer) or by intranasal (i.n.) instillation of a 200-microliter inoculum. In contrast, when organisms were delivered primarily to the upper respiratory tract by large-particle aerosol (8 micrometer) or by i.n. instillation of a small volume of inoculum (2 or 20 microliter), infection remained limited to this area in most or all instances. When the lungs became infected after i.n. administration of a 200-microliter inoculum, the most extensive pulmonary lesions were seen in the animals given the largest number of organisms. Each of the modes of administration of M. pneumoniae initiated an infection which conferred measurable resistance to a subsequent challenge capable of inducing extensive pulmonary disease. The most effective resistance was induced by the two modes of administration which produced an infection involving the entire respiratory tract, i.e., small-particle aerosol or i.n. instillation of a 200-microliter inoculum.
Similar articles
-
Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of route of administration on the immunogenicity and protective effect of inactivated M. pneumoniae vaccine.Infect Immun. 1977 Apr;16(1):88-92. doi: 10.1128/iai.16.1.88-92.1977. Infect Immun. 1977. PMID: 873618 Free PMC article.
-
Experimental infection of the respiratory tract with Mycoplasma pneumoniae.Environ Health Perspect. 1980 Apr;35:101-6. doi: 10.1289/ehp.8035101. Environ Health Perspect. 1980. PMID: 6773754 Free PMC article.
-
[Pathological anatomy of pneumonia in Mycoplasma pneumoniae infection in children].Arkh Patol. 1975;37(3):51-6. Arkh Patol. 1975. PMID: 1093526 Russian.
-
Response of guinea pigs and hamsters to experimental infection with Mycoplasma pneumoniae.Infection. 1976;4(1 Suppl):13-6. doi: 10.1007/BF01638415. Infection. 1976. PMID: 783045 Review.
-
Models of mycoplasma respiratory and genital tract infections.Wien Klin Wochenschr. 1997 Aug 8;109(14-15):569-73. Wien Klin Wochenschr. 1997. PMID: 9286061 Review.
Cited by
-
Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of route of administration on the immunogenicity and protective effect of inactivated M. pneumoniae vaccine.Infect Immun. 1977 Apr;16(1):88-92. doi: 10.1128/iai.16.1.88-92.1977. Infect Immun. 1977. PMID: 873618 Free PMC article.
-
Protective effect of vaccination against Mycoplasma pulmonis respiratory disease in rats.Infect Immun. 1978 Jul;21(1):69-75. doi: 10.1128/iai.21.1.69-75.1978. Infect Immun. 1978. PMID: 711323 Free PMC article.
-
Experimental infection of the respiratory tract with Mycoplasma pneumoniae.Environ Health Perspect. 1980 Apr;35:101-6. doi: 10.1289/ehp.8035101. Environ Health Perspect. 1980. PMID: 6773754 Free PMC article.
-
Pathogen delivery route impacts disease severity in experimental Mycoplasma ovipneumoniae infection of domestic lambs.Vet Res. 2025 Jan 13;56(1):10. doi: 10.1186/s13567-024-01439-y. Vet Res. 2025. PMID: 39806398 Free PMC article.
-
Development of an aerosol model of murine respiratory mycoplasmosis in mice.Infect Immun. 1986 Oct;54(1):194-201. doi: 10.1128/iai.54.1.194-201.1986. Infect Immun. 1986. PMID: 3759235 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources